急诊内科快速型心房颤动114例治疗观察

目的探讨急诊控制快速型心房颤动心室率的安全有效药物。方法将114例心房颤动、心室率〉120次/min的患者分为5组：A美托洛尔，B地尔硫至，C普罗帕酮，D毛花苷丙，E胺碘酮。多参数生命体征监护下静脉注射给药；设定心室率100次／min以下为目标，观察达标时间。结果A组（3.98±1.60）min，B组（7.15±2.54）min，C组（57.45±34.76）min，D组（57.47±34.75）min，E组（106.20±48.99）min；均达到预定心室率范围。结论心房颤动迅速控制心室率的时间，美托洛尔、地尔硫至、普罗帕酮三者依次延长，但差别无统计学意义；而毛花苷丙和胺碘酮时间明显长于前三者，差别有统计学意义。

Emergency treatment for 114 cases of patients with fast atrial fibrillation

Objective To find an efficiency and safe medicine for emergency control of the fast atrial fibrillation patient＇s ventricular rate. Methods One hundred and fourteen patients whose ventricular rate were more than 120/main were divided into five groups： A, metoprolol; B, dihiazem; C, proafenone; D, lanatoside; E, arninodaron. Less than 100/min ventricular rate was regarded as the normal and the time of achieving to the normal was observed. Results It took group A： （3.98±1.60）min, group B：（7.15±2.54）min, group C： （57.45±34.76）min, group D： （57.47±34.75）min, group E： （106.20±48.99）min to reach the normal ventricular rate. Conclusion As to the time of controlling the ventricular rate. The metoprolol, diltiazen and proafenone are less effective one by one, but they have no statistical signifcance. The lanatoside and aminodaron are much slower and the different was statistical significantly.